Announcement • Jun 30
Ginwa Enterprise (Group) Inc. to Report First Half, 2026 Results on Aug 22, 2026 Ginwa Enterprise (Group) Inc. announced that they will report first half, 2026 results on Aug 22, 2026 Announcement • Apr 29
Ginwa Enterprise (Group) Inc., Annual General Meeting, May 20, 2026 Ginwa Enterprise (Group) Inc., Annual General Meeting, May 20, 2026, at 13:30 China Standard Time. Location: 40F, South Tower, Phase 3, Fortune Center, Gaoxin 3rd Road, Xi'an, Shaanxi China Reported Earnings • Apr 29
Full year 2025 earnings released: EPS: CN¥0.044 (vs CN¥0.21 in FY 2024) Full year 2025 results: EPS: CN¥0.044 (down from CN¥0.21 in FY 2024). Revenue: CN¥544.0m (down 7.1% from FY 2024). Net income: CN¥15.6m (down 79% from FY 2024). Profit margin: 2.9% (down from 13% in FY 2024). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. New Risk • Apr 29
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.9% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.9% net profit margin). Announcement • Mar 30
Ginwa Enterprise (Group) Inc. to Report Q1, 2026 Results on Apr 25, 2026 Ginwa Enterprise (Group) Inc. announced that they will report Q1, 2026 results on Apr 25, 2026 New Risk • Jan 28
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 0.4% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (22% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows. Announcement • Dec 26
Ginwa Enterprise (Group) Inc. to Report Fiscal Year 2025 Results on Apr 25, 2026 Ginwa Enterprise (Group) Inc. announced that they will report fiscal year 2025 results on Apr 25, 2026 Reported Earnings • Nov 03
Third quarter 2025 earnings released: EPS: CN¥0.08 (vs CN¥0.057 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.08 (up from CN¥0.057 in 3Q 2024). Revenue: CN¥142.6m (down 18% from 3Q 2024). Net income: CN¥28.3m (up 33% from 3Q 2024). Profit margin: 20% (up from 12% in 3Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Announcement • Sep 30
Ginwa Enterprise (Group) Inc. to Report Q3, 2025 Results on Oct 30, 2025 Ginwa Enterprise (Group) Inc. announced that they will report Q3, 2025 results on Oct 30, 2025 New Risk • Sep 18
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 0.4% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (26% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows. Reported Earnings • Aug 22
Second quarter 2025 earnings released: EPS: CN¥0.014 (vs CN¥0.041 loss in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.014 (up from CN¥0.041 loss in 2Q 2024). Revenue: CN¥134.0m (up 2.9% from 2Q 2024). Net income: CN¥4.98m (up CN¥19.5m from 2Q 2024). Profit margin: 3.7% (up from net loss in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. Announcement • Jun 30
Ginwa Enterprise (Group) Inc. to Report First Half, 2025 Results on Aug 22, 2025 Ginwa Enterprise (Group) Inc. announced that they will report first half, 2025 results on Aug 22, 2025 Board Change • May 13
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Yajie Wu was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Apr 25
Full year 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.12 loss in FY 2023) Full year 2024 results: EPS: CN¥0.21 (up from CN¥0.12 loss in FY 2023). Revenue: CN¥585.5m (up 3.5% from FY 2023). Net income: CN¥74.6m (up CN¥117.5m from FY 2023). Profit margin: 13% (up from net loss in FY 2023). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Announcement • Apr 25
Ginwa Enterprise (Group) Inc., Annual General Meeting, May 15, 2025 Ginwa Enterprise (Group) Inc., Annual General Meeting, May 15, 2025, at 13:30 China Standard Time. Location: 40F, South Tower, Phase 3, Fortune Center, Gaoxin 3rd Road, Xi'an, Shaanxi China Announcement • Mar 28
Ginwa Enterprise (Group) Inc. to Report Q1, 2025 Results on Apr 25, 2025 Ginwa Enterprise (Group) Inc. announced that they will report Q1, 2025 results on Apr 25, 2025 Announcement • Dec 27
Ginwa Enterprise (Group) Inc. to Report Fiscal Year 2024 Results on Apr 25, 2025 Ginwa Enterprise (Group) Inc. announced that they will report fiscal year 2024 results on Apr 25, 2025 Reported Earnings • Oct 30
Third quarter 2024 earnings released: EPS: CN¥0.057 (vs CN¥0.001 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.057 (up from CN¥0.001 in 3Q 2023). Revenue: CN¥173.0m (up 17% from 3Q 2023). Net income: CN¥21.3m (up CN¥21.0m from 3Q 2023). Profit margin: 12% (up from 0.2% in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Announcement • Sep 30
Ginwa Enterprise (Group) Inc. to Report Q3, 2024 Results on Oct 30, 2024 Ginwa Enterprise (Group) Inc. announced that they will report Q3, 2024 results on Oct 30, 2024 Reported Earnings • Aug 17
Second quarter 2024 earnings released: CN¥0.041 loss per share (vs CN¥0.004 loss in 2Q 2023) Second quarter 2024 results: CN¥0.041 loss per share (further deteriorated from CN¥0.004 loss in 2Q 2023). Revenue: CN¥130.2m (down 12% from 2Q 2023). Net loss: CN¥14.5m (loss widened CN¥12.9m from 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Announcement • Jun 29
Ginwa Enterprise (Group) Inc. to Report First Half, 2024 Results on Aug 17, 2024 Ginwa Enterprise (Group) Inc. announced that they will report first half, 2024 results on Aug 17, 2024 Announcement • Apr 29
Ginwa Enterprise (Group) Inc., Annual General Meeting, May 17, 2024 Ginwa Enterprise (Group) Inc., Annual General Meeting, May 17, 2024, at 13:30 China Standard Time. Location: 40F, South Tower, Phase 3, Fortune Center, Gaoxin 3rd Road, Xi'an, Shaanxi China Reported Earnings • Apr 28
First quarter 2024 earnings released: EPS: CN¥0.065 (vs CN¥0.013 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.065 (up from CN¥0.013 in 1Q 2023). Revenue: CN¥115.8m (up 7.0% from 1Q 2023). Net income: CN¥24.0m (up 412% from 1Q 2023). Profit margin: 21% (up from 4.3% in 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance. Announcement • Mar 30
Ginwa Enterprise (Group) Inc. to Report Q1, 2024 Results on Apr 27, 2024 Ginwa Enterprise (Group) Inc. announced that they will report Q1, 2024 results on Apr 27, 2024 Announcement • Feb 22
Ginwa Enterprise (Group) Inc. (SHSE:600080) announces an Equity Buyback for CNY 150 million worth of its shares. Ginwa Enterprise (Group) Inc. (SHSE:600080) announces a share repurchase program. Under the program, the company will repurchase up to CNY 150 million worth of its A shares. The shares will be repurchased at a price not more than CNY 9.5 per share. The repurchased shares will be used for ESOP or equity incentives and for maintaining company value and shareholders’ equity. The authorization will be valid for a period of 6 months. Announcement • Dec 29
Ginwa Enterprise (Group) Inc. to Report Fiscal Year 2023 Results on Apr 27, 2024 Ginwa Enterprise (Group) Inc. announced that they will report fiscal year 2023 results on Apr 27, 2024 Reported Earnings • Nov 01
Third quarter 2023 earnings released: EPS: CN¥0.001 (vs CN¥0.028 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.001 (down from CN¥0.028 in 3Q 2022). Revenue: CN¥147.4m (down 10% from 3Q 2022). Net income: CN¥347.7k (down 97% from 3Q 2022). Profit margin: 0.2% (down from 6.3% in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Reported Earnings • Aug 19
Second quarter 2023 earnings released: CN¥0.004 loss per share (vs CN¥0.033 profit in 2Q 2022) Second quarter 2023 results: CN¥0.004 loss per share (down from CN¥0.033 profit in 2Q 2022). Revenue: CN¥147.1m (up 5.4% from 2Q 2022). Net loss: CN¥1.64m (down 113% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings. Board Change • Feb 12
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. Independent Director Ping Shi is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Board Change • Nov 16
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. Independent Director Ping Shi is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Oct 26
Third quarter 2022 earnings released: EPS: CN¥0.028 (vs CN¥0.016 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.028 (up from CN¥0.016 in 3Q 2021). Revenue: CN¥164.4m (up 11% from 3Q 2021). Net income: CN¥10.4m (up 68% from 3Q 2021). Profit margin: 6.3% (up from 4.1% in 3Q 2021). Over the last 3 years on average, earnings per share has fallen by 62% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings. Reported Earnings • Aug 21
Second quarter 2022 earnings released: EPS: CN¥0.033 (vs CN¥0.025 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.033 (up from CN¥0.025 in 2Q 2021). Revenue: CN¥139.5m (up 3.0% from 2Q 2021). Net income: CN¥12.2m (up 31% from 2Q 2021). Profit margin: 8.7% (up from 6.9% in 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Reported Earnings • Apr 27
First quarter 2022 earnings released: EPS: CN¥0.025 (vs CN¥0.024 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.025 (up from CN¥0.024 in 1Q 2021). Revenue: CN¥119.2m (up 12% from 1Q 2021). Net income: CN¥9.28m (up 23% from 1Q 2021). Profit margin: 7.8% (up from 7.1% in 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Reported Earnings • Oct 28
Third quarter 2021 earnings released: EPS CN¥0.016 (vs CN¥0.055 in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥148.8m (down 24% from 3Q 2020). Net income: CN¥6.15m (down 70% from 3Q 2020). Profit margin: 4.1% (down from 10% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 12% per year. Valuation Update With 7 Day Price Move • Sep 11
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥7.94, the stock trades at a trailing P/E ratio of 70.4x. Average trailing P/E is 31x in the Pharmaceuticals industry in China. Total loss to shareholders of 17% over the past three years. Valuation Update With 7 Day Price Move • Jun 07
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥7.68, the stock trades at a trailing P/E ratio of 59.1x. Average trailing P/E is 33x in the Pharmaceuticals industry in China. Total loss to shareholders of 20% over the past three years. Reported Earnings • Apr 25
First quarter 2021 earnings released: EPS CN¥0.02 (vs CN¥0.003 loss in 1Q 2020) The company reported a decent first quarter result with improved earnings and profit margins, although revenues were flat. First quarter 2021 results: Revenue: CN¥106.8m (flat on 1Q 2020). Net income: CN¥7.55m (up CN¥8.59m from 1Q 2020). Profit margin: 7.1% (up from net loss in 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Mar 16
New 90-day high: CN¥6.02 The company is up 5.0% from a price of CN¥5.72 on 16 December 2020. Outperformed the Chinese market which is down 2.0% over the last 90 days. Exceeded the Pharmaceuticals industry, which is down 8.0% over the same period. Is New 90 Day High Low • Jan 13
New 90-day low: CN¥5.20 The company is down 12% from its price of CN¥5.88 on 15 October 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is down 2.0% over the same period. Is New 90 Day High Low • Dec 12
New 90-day low: CN¥5.67 The company is down 7.0% from its price of CN¥6.10 on 11 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the Pharmaceuticals industry, which is also down 7.0% over the same period. Announcement • Nov 19
Liu Jiangtao completed the acquisition of an additional 45% stake in Shaanxi Jinhua Pharmaceutical Chemical Glass Co., Ltd. from Ginwa Enterprise (Group) Inc. (SHSE:600080). Liu Jiangtao intends to acquire an additional 45% stake in Shaanxi Jinhua Pharmaceutical Chemical Glass Co., Ltd. from Ginwa Enterprise (Group) Inc. (SHSE:600080) for CNY 2 million on October 28, 2020. Liu Jiangtao signed an equity transfer agreement to acquire an additional 45% stake in Shaanxi Jinhua Pharmaceutical Chemical Glass Co., Ltd. from Ginwa Enterprise (Group) Inc. (SHSE:600080) on October 30, 2020. As per consideration terms, within 10 working days after the entry into force of this agreement, Liu Jiangtao shall pay Ginwa Enterprise the transfer fee of CNY 2 million. In September 30, 2020, Shaanxi Jinhua Pharmaceutical Chemical Glass reported a total assets of CNY 31.2 million, negative net income of CNY 1.6 million, total common equity of -CNY 0.54 million and total revenues of CNY 47.3 million. The transaction was approved by the Board of Directors of Ginwa Enterprise (Group) Inc.
Liu Jiangtao completed the acquisition of an additional 45% stake in Shaanxi Jinhua Pharmaceutical Chemical Glass Co., Ltd. from Ginwa Enterprise (Group) Inc. (SHSE:600080) on November 19, 2020. Announcement • Oct 30
Liu Jiangtao intends to acquire an additional 45% stake in Shaanxi Jinhua Pharmaceutical Chemical Glass Co., Ltd. from Ginwa Enterprise (Group) Inc. (SHSE:600080) for CNY 2 million. Liu Jiangtao intends to acquire an additional 45% stake in Shaanxi Jinhua Pharmaceutical Chemical Glass Co., Ltd. from Ginwa Enterprise (Group) Inc. (SHSE:600080) for CNY 2 million on October 28, 2020. As per consideration terms, within 10 working days after the entry into force of this agreement, Liu Jiangtao shall pay Ginwa Enterprise the transfer fee of CNY 2 million. In September 30, 2020, Shaanxi Jinhua Pharmaceutical Chemical Glass reported a total assets of CNY 31.2 million, negative net income of CNY 1.6 million, total common equity of -CNY 0.54 million and total revenues of CNY 47.3 million. The transaction was approved by the Board of Directors of Ginwa Enterprise (Group) Inc. Reported Earnings • Oct 30
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥20.1m, down 54% from the prior year. Total revenue was CN¥664.8m over the last 12 months, down 11% from the prior year. Announcement • Jul 06
Ginwa Enterprise (Group) Inc. to Report First Half, 2020 Results on Aug 15, 2020 Ginwa Enterprise (Group) Inc. announced that they will report first half, 2020 results on Aug 15, 2020 
